26 . 06 .2023
Press release
Galderma raises approximately USD 1 billion for newly issued shares in a private placement round
05 . 06 .2023
Press release
Galderma receives FDA approval for its newest hyaluronic acid filler, Restylane® Eyelight™
19 . 04 .2023
Press release
Augmented reality: patient experience trumps misconceptions around injectables
30 . 03 .2023
Press release
AMWC 2023: Data from Sculptra® Cheek Wrinkle and Alluzience® Star Studies reinforce strength of Galderma’s broad aesthetic portfolio
22 . 03 .2023
Press release
Galderma launches FACE by Galderma™, a cutting-edge aesthetic visualization tool that simulates injectable treatment results in real-time
18 . 03 .2023
Press release
AAD 2023: Late-Breaking Phase III results demonstrate nemolizumab’s significant impact on prurigo nodularis